Poland· PL-100470624
Camcevi
A leuprorelin product containing leuprorelini mesilas, registered in Poland by Accord Healthcare S.L.U.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Leuprorelin is registered in 13 of 19 countries.
Countries holding a registration under ATC L02AE02 (leuprorelin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Leuprorelin · ATC L02AE02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of leuprorelin costs, country by country.
Normalised to the WHO defined daily dose (1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Leuprorelin · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$34.21
The record
At a glance
URPL (Poland)- Active substance
- Leuprorelini mesilas
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Poland (PL)
- ATC code
- L02AE02
- ATC class
- Leuprorelin
- Defined daily dose
- 1 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05055565796115
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
320 interactions on record for leuprorelin.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Leuprorelin · interactions on record
320 records
- 69 severe
- 248 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Leuprorelin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCamcevi 42 mgAccord Healthcare
- CzechiaCAMCEVIAccord Healthcare S.L.U., Barcelona
- SpainCAMCEVI 42 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADAAccord Healthcare S.L.U.
- United KingdomCamcevi 42mg prolonged-release suspension for injection pre-filled syringesAccord-UK Ltd
- IcelandCamceviAccord Healthcare S.L.U.
- SwedenCamcevi 42 mg Injektionsvätska, depotsuspensionAccord Healthcare S.L.U.
- NetherlandsCAMCEVI 21 mg suspensie voor injectie met verlengde afgifteAccord Healthcare S.L.U.
- FinlandCAMCEVIAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Eligard Depot, Enantone Monats-Depot
- Belgium · Depo-Eligard
- Bulgaria · Елигард, Лутрат Депо
- Cyprus · Eligard
- Czechia · Eligard, Leptoprol
- Germany · Eligard, Enantone Monats-Depot
- Denmark · Eligard, Leuprorelin Sandoz
- Estonia · Eligard
- Spain · Eligard Semestral, Eligard Trimestral
- Finland · Eligard, Enanton Depot Dual
- France · Eligard, Enantone Lp
- United Kingdom (Northern Ireland) · Prostap 3 Dcs, Prostap Pd Dcs
- Greece · Deplanda, Elityran
- Croatia · Eligard, Lerin
- Hungary · Eligard, Leuprorelin Pharmacenter
- Ireland · Eligard, Leuprex 3
- Iceland · Camcevi, Eligard
- Italy · Eligard, Enantone
- Liechtenstein · Camcevi
- Lithuania · Eligard
- Luxembourg · Depo-Eligard, Leugon
- Latvia · Eligard, Leptoprol
- Malta · Deplanda
- Netherlands · Eligard, Leuproreline Sandoz
- Norway · Camcevi, Eligard
- Portugal · Eligard, Lutrate Depot
- Romania · Eligard, Leptoprol
- Sweden · Eligard, Enanton Depot Dual
- Slovenia · Eligard, Leptoprol
- Slovakia · Eligard, Leuprorelin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7b45128-3b8a-49be-b891-a7f16eb6b44b GET /v1/drugs/e7b45128-3b8a-49be-b891-a7f16eb6b44b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina do wstrzykiwań o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "42 mg",
"packaging": "05055565796115 ¦ Rp ¦ EU/1/22/1647/001 ¦ 145609\n1 amp.-strzyk. ¦ 1 igła + 1 podstawka zabezpieczająca igłę",
"substance": "Leuprorelini mesilas 42 mg",
"common_name": "Leuprorelini mesilas",
"pl_product_id": "100470624",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about leuprorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.